Assignee
RECURSION PHARMACEUTICALS INC
US·34 granted patents·39 pending applications·37 citations·filing 2018–2025
Top patents by PatentIndex Score
73 records- 0191US10146914B1Systems and methods for evaluating whether perturbations discriminate an on target effectRECURSION PHARMACEUTICALS INC·Filed 2018·Granted Dec 4, 2018·17 cites·28 claims
- 0290US11791019B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Oct 17, 2023·1 cites·15 claims
- 0388US12119090B1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·4 cites·20 claims
- 0488US2024387003A1Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0587US11705223B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·1 cites·14 claims
- 0686US11919868B2Heterocyclic compounds and related methodsRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·24 claims
- 0785US12119091B1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·2 cites·20 claims
- 0885US2024029832A1Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0984US2025095392A1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1084US2025095146A1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1183US12073638B1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Aug 27, 2024·0 cites·20 claims
- 1282US12079992B1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 1382US10281456B1Systems and methods for discriminating effects on targetsRECURSION PHARMACEUTICALS INC·Filed 2018·Granted May 7, 2019·4 cites·30 claims
- 1481US2025322917A1Utilizing flow measures of a generative stochastic model and action values of an action-value model to generate structural representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1579US11393560B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2018·Granted Jul 19, 2022·2 cites·22 claims
- 1679US11361438B2Techniques for analyzing and detecting executional artifacts in microwell platesRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Jun 14, 2022·2 cites·20 claims
- 1779US2025078976A1Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1878US12300360B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2024·Granted May 13, 2025·0 cites·19 claims
- 1977US12374429B1Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfacesRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 2077US11715551B2Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Aug 1, 2023·1 cites·21 claims
- 2176US2025342912A1Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfacesRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2276US2026066039A1Training and using generative thermodynamics neural networks to determine binding affinities from energy distributionsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2376US2025201351A1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2475US11501853B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Nov 15, 2022·1 cites·18 claims
- 2574US12170135B2Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Dec 17, 2024·0 cites·22 claims
- 2674US12014804B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jun 18, 2024·0 cites·17 claims
- 2772US12528779B2Heterocyclic compounds and related methodsRECURSION PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·9 claims
- 2872US2026088138A1Active learning using coverage scoreRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2971US10743109B1Ordered picklist for liquid transferRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Aug 11, 2020·1 cites·21 claims
- 3071US2025225161A1Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration toolsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3171US2025225126A1Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration toolsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3270US2025391518A1Training and utilizing compound graph neural networks to generate biological activity predictions from input chemical compoundsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3370US2026038647A1Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3469US12525324B2Active learning using coverage scoreRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jan 13, 2026·0 cites·20 claims
- 3569US11612134B1Electronic monitor for experimental animalsRECURSION PHARMACEUTICALS INC·Filed 2021·Granted Mar 28, 2023·0 cites·20 claims
- 3669US2025342591A1Training and utilizing machine learning models to generate perturbation embeddings from phenomic images of cells, including neuronal cell imagesRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3768US12373950B1Training and utilizing machine learning models to generate perturbation embeddings from phenomic images of cells, including neuronal cell imagesRECURSION PHARMACEUTICALS INC·Filed 2025·Granted Jul 29, 2025·0 cites·20 claims
- 3867US12533356B2Pyrazolopyrimidine compounds as adenosine receptor antagonistsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jan 27, 2026·0 cites·12 claims
- 3967US12462903B2Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 4067US2026024614A1Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictionsRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4165US12494266B1Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictionsRECURSION PHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·0 cites·20 claims
- 4264US12009064B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2019·Granted Jun 11, 2024·0 cites·20 claims
- 4364US2025225321A1Generating large-language-model compatible sequential attachment-based fragment embedding molecular representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4464US2025225377A1Generating large-language-model compatible sequential attachment-based fragment embedding molecular representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4563US11109801B2Method of measuring efficacy of treatment for an autoimmune disease in vivarium animalsRECURSION PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·0 cites·3 claims
- 4663US2025391515A1Determining phenomic relationships between compounds and cell perturbations utilizing machine learning modelsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4762US2025356944A1Generating a mechanism of action representation from cell representation embeddings to predict a mechanism of action for a perturbationRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4860US2024092770A1Heterocycle RMB39 ModulatorsRECURSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4959US12462899B2Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 5057US12540149B2Aromatic heterocyclic compound, pharmaceutical composition, and use thereofRECURSION PHARMACEUTICALS INC·Filed 2021·Granted Feb 3, 2026·0 cites·3 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →